Panelists will discuss the past, present and future trends in life science financial markets. Healthcare companies have livened the public stock markets with significant gains over the last two years and more than 35 IPOs in 2013. This is a big development for the industry creating a whole new stable of public companies and resources to fund the next generation of medical innovation. The program moderator will be Douglas MacDougall, President of MacDougall Biomedical Communications.

The panel includes:

• Daniel B. Dubin, MD, Vice Chairman, Leerink Swann; Founder, MEDACorp
• Todd Foley, Managing Director, MPM Capital
• Peter Kolchinsky, PhD, Managing Partner, RA Capital Management, LLC
• David E. Redlick, Partner and Life Sciences Group Co-Chair, WilmerHale